Manuka Honey (Wound Care) for Antimicrobial Properties

Research suggests that Manuka honey possesses broad-spectrum antimicrobial properties, with laboratory studies, clinical case reports, and reviews collectively indicating activity against a range of bacteria relevant to wound care, including drug-resistant organisms such as MRSA, Pseudomonas aeruginosa, and E. coli. Studies indicate that these effects arise from multiple overlapping mechanisms — including methylglyoxal content, hydrogen peroxide release, high osmolarity, and low pH — and that Manuka honey may also disrupt bacterial biofilms and suppress virulence-related gene expression in pathogens like MRSA. The body of evidence is largely composed of in vitro laboratory studies, small clinical reports, and reviews, with only one randomized controlled trial identified, which found medical-grade honey comparable but not statistically superior to mupirocin for nasal MRSA decolonization. Importantly, research also highlights meaningful limitations, including variability in antimicrobial potency across products, questions about whether UMF grade labels reliably reflect actual antibacterial activity at the time of use, and a general need for larger, well-controlled clinical trials before definitive conclusions about therapeutic efficacy can be drawn.